True Wealth Design’s Rocket Pharmaceuticals RCKT Stock Holding History

True Wealth Design’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.99K	Buy	873 +171	+24%	+$569	﹤0.01%	1540
2026 Q1	$2.51K	Buy	702 +492	+234%	+$1.96K	﹤0.01%	1449
2025 Q4	$738	Hold	210	–	–	﹤0.01%	1823
2025 Q3	$685	Buy	+210	New	+$661	﹤0.01%	1897

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

True Wealth Design's RCKT Position: Q2 2026 in Review

True Wealth Design increased its Rocket Pharmaceuticals (RCKT) stake by 24% in Q2 2026, buying an estimated $569 and bringing the position to 873 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

True Wealth Design first reported a position in RCKT in Q3 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

True Wealth Design held 873 shares of Rocket Pharmaceuticals worth $2.99K as of Q2 2026.
True Wealth Design bought 171 Rocket Pharmaceuticals shares in Q2 2026, an estimated $569.
Rocket Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1540 holding.
True Wealth Design first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.